Ogen and Procardia drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ogen (estropipate) and Procardia (nifedipine). Common drug interactions include gingivitis among females.
The phase IV clinical study analyzes what interactions people have when they take Ogen and Procardia. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Ogen?
Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.
What is Procardia?
Procardia has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 15,151 Procardia users. Check the latest studies of Procardia.
13 people who take Ogen and Procardia together, and have interactions are studied.
What are the common drug interactions of Ogen and Procardia, by gender? *:
female:
- Gingivitis (inflammation of gums)
- Breast enlargement
- Burning sensation
- Cardiac disorder
- Cardiac failure congestive
- Cardiomegaly (increased size of heart than normal)
- Colonic polyp (extra part of colon tissue grow in intestine)
- Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
- Drug ineffective
- Dysphagia (a condition in which swallowing is difficult or painful)
male:
n/a
What are the common drug interactions of Ogen and Procardia, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Gingivitis (inflammation of gums)
- Breast enlargement
- Tension headaches
- Headache (pain in head)
- Breast disorder
- Cardiomegaly (increased size of heart than normal)
- Oedema lower limb (fluid collection in tissue of lower leg)
- Reaction to drug excipient
- Skin atrophy (wasting of skin)
60+:
- Abdominal pain
- Abdominal pain lower
- Faecal occult blood positive
- Flushing (the warm, red condition of human skin)
- Gingival bleeding (bleeding gums)
- Gingivitis (inflammation of gums)
- Haematocrit decreased
- Hypersensitivity
- Hypoaesthesia (reduced sense of touch or sensation)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
* Approximation only. Some reports may have incomplete information.
Do you take Ogen and Procardia?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ogen and Procardia:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Procardia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ogen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Procardia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on estropipate and nifedipine (the active ingredients of Ogen and Procardia, respectively), and Ogen and Procardia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Alprazolam cause Mean Cell Haemoglobin Decreased? - 2 seconds ago
- Could Alprazolam cause Infusion Site Oedema? - 5 seconds ago
- Drug interactions of Aripiprazole and Nexium 24Hr - 13 seconds ago
- Could Sandostatin cause Metastatic Neoplasm? - 17 seconds ago
- Drug interactions of Diazepam and Melatonin - 29 seconds ago
- Could Acetylsalicylic Acid cause Skeletal Injury? - 36 seconds ago
- Could Temaz cause Metastases To Liver? - 40 seconds ago
- Drug interactions of Flarex and Tylenol - 44 seconds ago
- Could Glynase cause Sepsis? - 45 seconds ago
- Drug interactions of Aricept and Zoledronic - 59 seconds ago